{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:17:28Z","timestamp":1775265448368,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NCIS Seed Fund"},{"DOI":"10.13039\/501100001349","name":"NMRC-NIG grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.pathol.2020.07.017","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T18:45:19Z","timestamp":1605033919000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["YJ5 as an immunohistochemical marker of osteogenic lineage"],"prefix":"10.1016","volume":"53","author":[{"given":"Kenon","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6976-850X","authenticated-orcid":false,"given":"David M.","family":"Virshup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-7392","authenticated-orcid":false,"given":"Eugene G.","family":"Odono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth Tou En","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas Jin Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Swee-Shan","family":"Hue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Yi Loong","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Kwan Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2020.07.017_bib1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2020.07.017_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diff.2012.06.004","article-title":"A\u00a0uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities","volume":"84","author":"Najdi","year":"2012","journal-title":"Differentiation"},{"key":"10.1016\/j.pathol.2020.07.017_bib3","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1007\/s13277-014-2433-8","article-title":"Wnt\/\u03b2-catenin pathway in bone cancers","volume":"35","author":"Tian","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pathol.2020.07.017_bib4","doi-asserted-by":"crossref","first-page":"a011163","DOI":"10.1101\/cshperspect.a011163","article-title":"Wnt signaling","volume":"4","author":"Nusse","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.pathol.2020.07.017_bib5","doi-asserted-by":"crossref","first-page":"18991","DOI":"10.18632\/oncotarget.15086","article-title":"Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2020.07.017_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcp.25853","article-title":"New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway","volume":"233","author":"Ge","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.pathol.2020.07.017_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cas.12655","article-title":"Targeting the canonical Wnt\/\u03b2-catenin pathway in hematological malignancies","volume":"106","author":"Ashihara","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2020.07.017_bib8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/modpathol.2014.114","article-title":"Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression","volume":"28","author":"Stewart","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib9","doi-asserted-by":"crossref","first-page":"e2197","DOI":"10.1073\/pnas.1120407109","article-title":"Wntless functions in mature osteoblasts to regulate bone mass","volume":"109","author":"Zhong","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2020.07.017_bib10","doi-asserted-by":"crossref","first-page":"29ra30","DOI":"10.1126\/scitranslmed.3000231","article-title":"Wnt proteins promote bone regeneration","volume":"2","author":"Minear","year":"2010","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2020.07.017_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2106\/JBJS.G.01174","article-title":"Wnt and hedgehog signaling pathways in bone development","volume":"90","author":"Day","year":"2008","journal-title":"J\u00a0Bone Jt Surg Am"},{"key":"10.1016\/j.pathol.2020.07.017_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9440(10)63696-6","article-title":"Classification and subtype prediction of adult soft tissue sarcoma by functional genomics","volume":"163","author":"Segal","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/pbc.20124","article-title":"Wnt\/Frizzled signaling in Ewing sarcoma","volume":"43","author":"Uren","year":"2004","journal-title":"Pediatr Blood"},{"key":"10.1016\/j.pathol.2020.07.017_bib14","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1158\/2159-8290.CD-13-0138","article-title":"Targeting the Wnt pathway in synovial sarcoma models","volume":"3","author":"Barham","year":"2013","journal-title":"Canc Discov"},{"key":"10.1016\/j.pathol.2020.07.017_bib15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2013.97","article-title":"Characterization of Wnt\/\u03b2-catenin signaling in rhabdomyosarcoma","volume":"93","author":"Annavarapu","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.pathol.2020.07.017_bib16","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/onc.2013.443","article-title":"SS18-SSX fusion protein-induced Wnt\/\u03b2-catenin signaling is a therapeutic target in synovial sarcoma","volume":"33","author":"Trautmann","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.pathol.2020.07.017_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cell.2006.04.009","article-title":"Secretion of Wnt ligands requires Evi, a conserved transmembrane protein","volume":"125","author":"Bartscherer","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2020.07.017_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cell.2006.02.049","article-title":"Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells","volume":"125","author":"B\u00e4nziger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2020.07.017_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbagen.2013.11.003","article-title":"Canonical Wnt signaling differently modulates osteogenic differentiation of mesenchymal stem cells derived from bone marrow and from periodontal ligament under inflammatory conditions","volume":"1840","author":"Liu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pathol.2020.07.017_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.446","article-title":"Genetic Factors for Osteoporosis (GEFOS) Consortium. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies","volume":"41","author":"Rivadeneira","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2020.07.017_bib21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/dvdy.24316","article-title":"Wntless spatially regulates bone development through \u03b2-catenin-dependent and independent mechanisms","volume":"244","author":"Zhong","year":"2015","journal-title":"Dev Dyn"},{"key":"10.1016\/j.pathol.2020.07.017_bib22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/modpathol.2014.40","article-title":"Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas","volume":"27","author":"Singhi","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib23","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/carcin\/bgu166","article-title":"Wntless (GPR177) expression correlates with poor prognosis in B-cell precursor acute lymphoblastic leukemia via Wnt signaling","volume":"35","author":"Chiou","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pathol.2020.07.017_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/emmm.201100186","article-title":"The Wnt secretion protein Evi\/Gpr177 promotes glioma tumourigenesis","volume":"4","author":"Augustin","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.pathol.2020.07.017_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/apm.12534","article-title":"Expression of Wntless in colorectal carcinomas is associated with invasion, metastasis, and poor survival","volume":"124","author":"Xu","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.pathol.2020.07.017_bib26","series-title":"WHO Classification of Tumours of Bone and Soft Tissue","year":"2013"},{"key":"10.1016\/j.pathol.2020.07.017_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.devcel.2014.03.016","article-title":"WLS retrograde transport to the endoplasmic reticulum during Wnt secretion","volume":"29","author":"Yu","year":"2014","journal-title":"Dev Cell"},{"key":"10.1016\/j.pathol.2020.07.017_bib28","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1242\/jcs.072132","article-title":"WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification","volume":"123","author":"Coombs","year":"2010","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.pathol.2020.07.017_bib29","doi-asserted-by":"crossref","first-page":"17570","DOI":"10.18632\/oncotarget.4100","article-title":"Aberrant activation of Wnt\/\u03b2-catenin signaling drives proliferation of bone sarcoma cells","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2020.07.017_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2012.12.118","article-title":"Inhibition of the Wnt-\u03b2-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy","volume":"431","author":"Ma","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pathol.2020.07.017_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/138945008784911796","article-title":"Wnt signaling in development, disease and translational medicine","volume":"9","author":"Coombs","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pathol.2020.07.017_bib32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/0008-5472.CAN-12-2258","article-title":"Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer","volume":"73","author":"Proffitt","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14728220902841961","article-title":"Wnt signaling as a therapeutic target for bone diseases","volume":"13","author":"Hoeppner","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pathol.2020.07.017_bib34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12032-015-0585-z","article-title":"Wls promotes the proliferation of breast cancer cells via Wnt signaling","volume":"32","author":"Lu","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.pathol.2020.07.017_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.07.017_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.prp.2016.06.012","article-title":"The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas","volume":"212","author":"Machado","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2020.07.017_bib38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/his.12911","article-title":"Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas","volume":"69","author":"Davis","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.07.017_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/PAS.0b013e31821c3dae","article-title":"SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas","volume":"35","author":"Magnusson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/PAP.0000000000000001","article-title":"SATB2 is a novel marker of osteoblastic differentiation and colorectal adenocarcinoma","volume":"21","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1309\/AJCPWW2URZ9JKQJU","article-title":"The role of SATB2 as a diagnostic marker for tumors of colorectal origin: results of a pathology-based clinical prospective study","volume":"141","author":"Dragomir","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/embor.2010.125","article-title":"SATB2 augments \u0394Np63\u03b1 in head and neck squamous cell carcinoma","volume":"11","author":"Chung","year":"2010","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pathol.2020.07.017_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00403-016-1655-6","article-title":"SATB2 is expressed in Merkel cell carcinoma","volume":"308","author":"Fukuhara","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/his.13943","article-title":"SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas","volume":"76","author":"Bellizzi","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2020.07.017_bib45","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jclinpath-2015-203588","article-title":"Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas","volume":"69","author":"Kim","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib46","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.21873\/anticanres.12784","article-title":"Diagnostic utility of Prostein, Uroplakin II and SATB2 for diagnosing carcinoma of unknown primary origin: a systematic immunohistochemical profiling","volume":"38","author":"Mochizuki","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib47","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jbmr.1830","article-title":"Gpr177, a novel locus for bone mineral density and osteoporosis, regulates osteogenesis and chondrogenesis in skeletal development","volume":"28","author":"Maruyama","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<463::AID-PATH476>3.0.CO;2-N","article-title":"Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm","volume":"189","author":"Aigner","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.pathol.2020.07.017_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BLO.0b013e31804856a1","article-title":"Properties of the stromal cell in giant cell tumor of bone","volume":"459","author":"Ghert","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI112838","article-title":"Human giant cell tumors of bone identification and characterization of cell types","volume":"79","author":"Goldring","year":"1987","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2020.07.017_bib52","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s11999-008-0327-z","article-title":"Histogenetic characterization of giant cell tumor of bone","volume":"466","author":"Salerno","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2012.10.002","article-title":"Giant cell tumor of bone: a basic science perspective","volume":"52","author":"Cowan","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.pathol.2020.07.017_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11914-017-0377-9","article-title":"Wnt signaling in ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors","volume":"15","author":"Pridgeon","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.pathol.2020.07.017_bib55","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1158\/0008-5472.CAN-15-3422","article-title":"Activation of Wnt\/\u03b2-Catenin in Ewing Sarcoma cells antagonizes EWS\/ETS function and promotes phenotypic transition to more metastatic cell states","volume":"76","author":"Pedersen","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2020.07.017_bib56","doi-asserted-by":"crossref","first-page":"22113","DOI":"10.1038\/srep22113","article-title":"The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma","volume":"6","author":"Cironi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2020.07.017_bib57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0081","article-title":"Canonical Wnt\/\u03b2-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance","volume":"3","author":"Watson","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pathol.2020.07.017_bib58","doi-asserted-by":"crossref","first-page":"42429","DOI":"10.18632\/oncotarget.6464","article-title":"Genomic landscape of liposarcoma","volume":"6","author":"Kanojia","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2020.07.017_bib59","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1038\/s41598-019-39560-0","article-title":"miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGF\u03b2, and Wnt signaling","volume":"9","author":"Mazzu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2020.07.017_bib60","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1016\/j.bmcl.2009.04.040","article-title":"Structure-activity relationship studies of small-molecule inhibitors of Wnt response","volume":"19","author":"Lu","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pathol.2020.07.017_bib61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pathol.2020.07.017_bib62","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/pro.3122","article-title":"Modulating the wnt signaling pathway with small molecules","volume":"26","author":"Tran","year":"2017","journal-title":"Protein Sci"},{"key":"10.1016\/j.pathol.2020.07.017_bib63","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2017.35.15_suppl.2584","article-title":"First-in-human phase 1 study of ETC-159 an oral PORCN inhibitor in patients with advanced solid tumours","volume":"35","author":"Ng","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520309429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302520309429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:26:49Z","timestamp":1758472009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302520309429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0031302520309429"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2020.07.017","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YJ5 as an immunohistochemical marker of osteogenic lineage","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2020.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}